Literature DB >> 16892910

Estimating vaccine efficacy from outbreak size household data in the presence of heterogeneous transmission probabilities.

X M Davis1, L A Waller, M Haber.   

Abstract

We develop a Bayesian approach for estimating vaccine efficacy for susceptibility (VEs) and infectiousness (VEI) using outbreak size household data. Our method allows for heterogeneity in transmission probabilities due to factors that are related to individuals' characteristics, such as age, in addition to vaccination status. It also allows for between-household heterogeneity in transmission probabilities due to random effects associated with households, such as genetic or environmental effects. Using age as a potential covariate causing heterogeneity in individuals' transmission probabilities in households consisting of adults and children, we present the results of a simulation study designed to evaluate the performance of the proposed estimators of VEs and VE(I). We found that estimates of VE(I) have larger bias and variance compared to those of VEs. We also use the approach to compare two vaccination designs: one vaccinating both adults and children, the other only children. Simulations reveal that the design that vaccinates both adults and children provides better estimates of VEs. There is no obvious difference between the two designs in the performance of the estimates of VE(I). In regard to random effects between households and the scenarios considered, models that do not account for between-households heterogeneity produce fairly robust estimates even when household-level random effects are present.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16892910     DOI: 10.1080/10543400600719467

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  1 in total

1.  Estimating vaccine efficacy under the heterogeneity of vaccine action in a nonrandomly mixing population.

Authors:  M Shafiqur Rahman
Journal:  J Biopharm Stat       Date:  2013-03-11       Impact factor: 1.051

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.